人工血管内シャント吻合部狭窄用途の米国臨床試験（Gore REVISE Clinical Study）¹

浅大腿動脈における症候性末梢動脈疾患患者にバイアバーン® ステントグラフトを使用した国内臨床試験²

主な登録患者背景

^* Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ 

^† Statistical comparison between the two treatment groups reported a p-value less than 0.001

^‡ Percentages based on effectiveness population for the GORE® VIABAHN® Device group (n = 131) and the PTA group (n = 138)

1. Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. Journal of Vascular Surgery 2016;64(5):1400-1410.el. https://www.sciencedirect.com/science/article/pii/S0741521416301756.

2. Ohki T, Kichikawa K, Yokoi H, et al. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery. Journal of Vascular Surgery 2021;74(6):1958-1967.e2. https://www.sciencedirect.com/science/article/pii/S0741521421010119